Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

AnticoagEvaluator icon
AnticoagEvaluator4.7 (71)

American College of Cardiology

App Store

Report updated Apr 30, 2026

Overview · Full Intel report in progress

AnticoagEvaluator is an established medical app that is completely free. With a 4.7/5 rating from 71 reviews, it shows polarized user reception.

What is AnticoagEvaluator?

AnticoagEvaluator is a medical tool developed by the American College of Cardiology to assist clinicians in managing antithrombotic therapy for patients with non-valvular atrial fibrillation. The app provides guideline-driven therapy guidance and risk assessment based on the SPARC Tool methodology.

Current Momentum

v5.0 · 17mo ago

Zombie

Last updated 524d ago. 5 versions tracked.

Competition

Rivals identification in progress

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

MedicalGrossing

Rating Pulse 🇺🇸

What makes this app unique?

What Does It Look Like?

What Are The Key Features?

Risk AssessmentStandard

Calculates a patient's renal function and risk levels for ischemic stroke, thromboembolism, and bleeding.

Guideline-Driven TherapyStandard

Provides ACC/AHA/HRS clinical guidance for stroke prevention strategies.

Individualized Risk AnalysisStandard

Generates therapy options based on clinical trial data tailored to specific patient characteristics.

DOAC Dosage OptimizationStandard

Assists in the accurate use of direct oral anticoagulants by adjusting dosages based on renal function and patient-specific data.

How much does it cost?

Free

Who Built It?

American College of Cardiology app icon 1
American College of Cardiology app icon 2
American College of Cardiology app icon 3
American College of Cardiology app icon 4

American College of Cardiology

(3.9K)

Providing cardiovascular clinicians with evidence-based decision support tools and professional educational resources. Standardizing cardiac care through mobile-accessible guidelines and risk modeling.

Portfolio

13

Apps

Free 12
Medical75%
Reference17%
Education8%

Explore the full American College of Cardiology report

Portfolio breakdown, audience, momentum, and every app published by American College of Cardiology.

Go deeper

Analysis in progress, available soon

What do users think recently?

Analysis in progress, available soon

View the full user-sentiment analysis

Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.

Go deeper

Analysis in progress, available soon

What is the competitive landscape for AnticoagEvaluator?

How's The Medical Market?

Market outlook for this category

Available very soon

Strategic analysis coming soon

SWOT, key takeaways & outlook

The outtake for AnticoagEvaluator

Key Takeaways

While the app offers specialized clinical decision support, recent user feedback indicates potential technical instability regarding therapy detail navigation.

Where Is It Heading?

Trend analysis

Available very soon

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by AnticoagEvaluator, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Cite this report

Marlvel.ai. “AnticoagEvaluator Intelligence Report.” Updated Apr 30, 2026. https://marlvel.ai/apps/anticoagevaluator

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0